ArticleFrontiers in oncology2020

Identification of a Metabolism-Related Risk Signature Associated With Clinical Prognosis in Glioblastoma Using Integrated Bioinformatic Analysis.

Zheng He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.